Hassane M Zarour Selected Research

Amino Acids

5/2013

Strategies to reverse melanoma-induced T-cell dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hassane M Zarour Research Topics

Disease

36	Neoplasms (Cancer) 10/2022 - 01/2002
30	Melanoma (Melanoma, Malignant) 01/2022 - 01/2002
2	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Disease Progression 01/2020
1	Nevus (Nevi) 01/2018
1	Leukemia 04/2016
1	Lymphoma (Lymphomas) 04/2016
1	Virus Diseases (Viral Diseases) 04/2016
1	Human Influenza (Influenza) 05/2009

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2022 - 01/2002
10	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2008
9	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
8	VaccinesIBA 01/2021 - 03/2003
8	EpitopesIBA 02/2012 - 01/2002
7	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2010
7	AntigensIBA 01/2022 - 09/2002
6	Cancer VaccinesIBA 02/2014 - 01/2002
5	LigandsIBA 01/2020 - 05/2013
5	HLA-DR Antigens (HLA-DR)IBA 12/2007 - 01/2002
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
4	CytokinesIBA 05/2013 - 03/2003
4	Immunodominant EpitopesIBA 01/2011 - 05/2002
3	CTLA-4 AntigenIBA 10/2022 - 05/2013
3	pembrolizumabIBA 01/2022 - 10/2018
2	MucinsIBA 01/2022 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 05/2015
2	B7-H1 AntigenIBA 01/2020 - 05/2009
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	AntibodiesIBA 11/2015 - 01/2002
2	Interleukin-10 (Interleukin 10)IBA 04/2015 - 05/2013
2	Interleukin-2 (IL2)IBA 09/2010 - 07/2008
2	InterferonsIBA 07/2008 - 09/2002
2	HLA-DP Antigens (HLA-DP)IBA 12/2007 - 02/2005
2	HLA-DRB1*04:01 antigenIBA 10/2003 - 01/2002
2	AutoantigensIBA 05/2002 - 01/2002
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	incomplete Freund's adjuvantIBA 01/2021
1	poly ICLCIBA 01/2021
1	IpilimumabIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	peginterferon alfa-2b (Pegintron)FDA Link 10/2018
1	DecorinIBA 01/2018
1	sulforaphaneIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 04/2016
1	Blocking AntibodiesIBA 11/2015
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2013
1	Amino Acids FDA Link 05/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 05/2013
1	EnzymesIBA 05/2013
1	MART-1 AntigenIBA 05/2009
1	mannide monooleateIBA 10/2008
1	Monatide (IMS 3015)IBA 10/2008
1	ProMune (CpG 7909)IBA 10/2008
1	Adenosine (Adenocard)FDA LinkGeneric 06/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	HLA-DPw4 antigenIBA 02/2005
1	Interleukin-5 (Interleukin 5)IBA 02/2005
1	Histocompatibility Antigens Class IIIBA 09/2002
1	Sulfhydryl Compounds (Thiols)IBA 05/2002
1	Oxidoreductases (Dehydrogenase)IBA 05/2002
1	Interferon-gamma (Interferon, gamma)IBA 05/2002

Therapy/Procedure

13	Immunotherapy 10/2022 - 06/2007
13	Therapeutics 10/2022 - 07/2008
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Immunomodulation 01/2022 - 07/2008
2	Radiotherapy 01/2020 - 11/2015
1	Fecal Microbiota Transplantation 01/2021
1	Chemoprevention 01/2018